Back to results
US 2026/0309721 A1Published application
C3-HNE Assay
AssigneeNordic Bioscience A/S
InventorsThomai Tsapanou Katranara, Joachim Høg Mortensen, Marta Alexdottir, Morten A. Karsdal
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of immunoassay for detecting HNE-generated fragments of the α1 chain of type III collagen in a patient sample, and the use thereof for detecting and/or monitoring inflammatory bowel disease (IBD) or a particular level of severity thereof in a patient. The present invention also relates to monoclonal antibodies and assay kits for use in said methods of immunoassay.
Claims14
1:
- A method of immunoassay, said method comprising;
- i) contacting a patient sample with a monoclonal antibody that specifically binds to the N-terminus amino acid sequence PGKNGERGGP (SEQ ID NO:
- 1);
- and
- ii) detecting and determining the amount of binding between said monoclonal antibody and peptides in the sample.
2 more elements
2:
- The method as claimed in claim 1, wherein the method is a method of immunoassay for detecting and/or monitoring inflammatory bowel disease or a particular level of severity thereof in a patient, the method further comprising;
- ii) correlating said amount of binding with values associated with normal healthy subjects and/or values associated with known disease severity and/or values obtained from said patient at a previous time point and/or with a predetermined cut-off value.
3:
- The method as claimed in claim 2, wherein the inflammatory bowel disease is Crohn's disease or ulcerative colitis.
4:
- The method as claimed in claim 1, wherein the patient sample is selected from blood, plasma or serum.
5:
- The method as claimed in claim 1, wherein the monoclonal antibody specifically binds to the N-terminus amino acid sequence PGKNGERGGP (SEQ ID NO:
- 1) and does not specifically bind to a peptide having the N-terminus amino acid sequence APGKNGERGGP(SEQ ID NO:
- 2).
6:
- The method as claimed in claim 1, wherein the monoclonal antibody specifically binds to the N-terminus amino acid sequence PGKNGERGGP (SEQ ID No:
- 1) and does not specifically bind to a peptide having the N-terminus amino acid sequence GKNGERGGP (SEQ ID NO:
- 3).
7:
- The method as claimed in claim 1, wherein the monoclonal antibody is raised against a synthetic peptide having the N-terminus amino acid sequence PGKNGERGGP (SEQ ID NO:
- 1).
8:
- The method as claimed in claim 1, wherein the immunoassay is a competition assay or a sandwich assay.
9:
- The method as claimed in claim 1, wherein the immunoassay is a radio-immunoassay or an enzyme-linked immunosorbent assay.
10:
- A monoclonal antibody that specifically recognises the N-terminus amino acid sequence PGKNGERGGP(SEQ ID NO:
- 1).
11:
- The monoclonal antibody as claimed in claim 10 [13], wherein the monoclonal antibody specifically binds to the N-terminus amino acid sequence PGKNGERGGP (SEQ ID NO:
- 1) and does not specifically bind to a peptide having the N-terminus amino acid sequence APGKNGERGGP (SEQ ID NO:
- 2).
12:
- The monoclonal antibody as claimed in claim 10, wherein the monoclonal antibody specifically binds to the N-terminus amino acid sequence PGKNGERGGP(SEQ ID NO:
- 1) and does not specifically bind to a peptide having the N-terminus amino acid sequence GKNGERGGP (SEQ ID NO:
- 3).
13:
- The monoclonal antibody as claimed in 10, wherein the monoclonal antibody is raised against a synthetic peptide having the N-terminus amino acid sequence PGKNGERGGP (SEQ ID NO:
- 1).
14:
- An immunoassay kit comprising the monoclonal antibody as claimed in claim 10, and at least one of:
- a streptavidin coated well plate;
- a biotinylated peptide PGKNGERGGP-L-Biotin (SEQ ID NO:
- 20), wherein L is an optional linker;
- a secondary antibody for use in a sandwich immunoassay;
- a calibrator protein comprising the N-terminus amino acid sequence PGKNGERGGP (SEQ ID NO:
- 1);
- an antibody biotinylation kit;
- an antibody HRP labelling kit;
- or
- an antibody radiolabelling kit.
8 more elements